Form D — Avicenna Biosciences, Inc.
0001824034-25-000002 · filed 2025-10-30
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $70,650
- Total sold
- $70,650
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Avicenna Biosciences, Inc.
- CIK
- 1824034
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 101 W. CHAPEL HILL STREET, SUITE 210
DURHAM, NC 27701 - Phone
- 919-667-2504
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Meldrum · Executive OfficerDurham, NC Find on LinkedIn ↗
-
Thomas Kaiser · Executive OfficerDurham, NC Find on LinkedIn ↗
-
Pieter Burger · Executive OfficerDurham, NC Find on LinkedIn ↗
-
John Hamer · DirectorDurham, NC Find on LinkedIn ↗
-
Dennis Langer · DirectorDurham, NC Find on LinkedIn ↗
View original on SEC EDGAR.